Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Wolters Kluwer full text link Wolters Kluwer Free PMC article
Full text links

Actions

Share

.2020 Feb;30(2):26-33.
doi: 10.1097/FPC.0000000000000392.

PharmGKB summary: sertraline pathway, pharmacokinetics

Affiliations

PharmGKB summary: sertraline pathway, pharmacokinetics

Rachel Huddart et al. Pharmacogenet Genomics.2020 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Stylized diagram showing sertraline metabolism in the liver. A fully clickable version of this figure can be found athttps://www.pharmgkb.org/pathway/PA166181117.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pfizer, Zoloft Prescribing Information. Revised December 2016.
    1. Gupta RN and Dziurdzy SA, Therapeutic monitoring of sertraline. Clin Chem, 1994. 40(3): p. 498–9. - PubMed
    1. Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, et al., Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2010(4): p. Cd006117. - PMC - PubMed
    1. Tabak F, Gunduz F, Tahan V, Tabak O, and Ozaras R, Sertraline hepatotoxicity: report of a case and review of the literature. Dig Dis Sci, 2009. 54(7): p. 1589–91. - PubMed
    1. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al., Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol, 2008. 128(1): p. 35–44. - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Wolters Kluwer full text link Wolters Kluwer Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp